An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents
Stephanie E. Barrett(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven L. Colletti(Merck & Co., Inc., Rahway, NJ, USA (United States)), Eric Kemp, Nicole T. Pudvah(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marc Abrams(Dicerna Pharmaceuticals (United States)), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Robert A. Kowtoniuk(United States Military Academy), Mihir Patel(United States Military Academy), Bonnie J. Howell(Johns Hopkins University), Eileen S. Walsh(Janssen (Switzerland)), Anthony Leone, Sean Riley(United States Military Academy), Brian Carr, Andrew H. Latham(United States Military Academy), Rob S. Burke(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sergei Pechenov(United States Military Academy), Jonathan Williams(University of Liverpool), Louis S. Crocker, R. M. Garbaccio(United States Military Academy), Karen Leander(United States Military Academy)
Cited by 16
Related Papers
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
|Science|1993|2.3k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409